Live Breaking News & Updates on Contact Sigyn Therapeutics Inc
Stay updated with breaking news from Contact sigyn therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. The Closing Bell Featuring Sigyn Therapeutics Sigyn Therapeutics, Inc.April 21, 2021 GMT The Interactive Videoconference Occurs Today at 4pm Eastern / 1pm Pacific Time SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) via NewMediaWire Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome, announces that its Chairman and CEO, Jim Joyce, will be featured on the Closing Bell videoconference hosted by Force Family Offices at 4pm Eastern today. This interactive event provides investors with an opportunity to talk directly with Mr. Joyce regarding the advancement of Sigyn Therapy™, a novel blood purification technology designed to treat sepsis and other life-threatening conditions that are induced by cytokine storm syndrome. Also participating in ....
Sigyn Therapeutics™ Discloses In-Vitro Viral Pathogen Study apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, March 08, 2021 via NewMediaWire Sigyn Therapeutics, Inc. , a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by. | March 12, 2021 ....
Sigyn Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Sigyn Therapeutics (SIGY) CEO Note: Overcoming the Limitations of Previous Cytokine Storm Treatment Strategies SAN DIEGO, Jan. 12, 2021 via NewMediaWire Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. Dear Current and Candidate Shareholders, We created Sigyn Therapy to address a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome (the Cytokine Storm). An annual market opportunity that exceeds $20 billion. Based on our cumulative experience in developing first-in-industry medical technologies, we designed Sigyn Therapy to overcome the limitations of previous strategies to treat cytokine storm related conditions, yet still optimize patient safety and support widespread deployment. ....